Curative and Truepill have announced a partnership to give patients who test positive for COVID-19 at a Curative testing site easy access to telehealth and next-day antiviral treatment options. This partnership will provide Texans access to treatment for Curative patients who test positive for COVID-19.

After taking a COVID-19 molecular or antigen test at a Curative testing site, results are delivered directly to the patient. If they test positive, they can take advantage of Truepill's convenient COVID-19 virtual care platform to access antiviral treatment options quickly and easily.

Patients who test positive within five days of mild to moderate symptom onset will have access to on-demand telehealth consults with US-licensed healthcare professionals. If eligible, an antiviral prescription will be shipped directly to their door or sent to their local pharmacy. By leveraging Truepill's scalable direct-to-patient telehealth platform and nationwide prescription fulfillment and delivery capabilities, Curative ensures all eligible patients have access to the treatment they need.

Curative's COVID-19 testing appointments are available nationwide. Visit curative.com to book a testing appointment and see the full range of Curative's offerings. More information on Truepill and its telehealth, diagnostics, and pharmacy services are available at truepill.com.